Manufacturer recalls accolade pacemaker devices

Manufacturer recalls accolade pacemaker devices


Boston scientific has issued a reclal of accolade pacemaker devices, according to a safety communication from the us food and Drug Administration.

The Accolade devices under recall Include the acclade, proponent, essentio, and altrua 2 standard life and extended life pacemakers and the visionist and valitude CardiChanchronization Therapy Pacemakers.

The devices are being recalled due to an increase risk of permanently entering safety mode. Safety mode has limited functionality and is associateed with the pacmaker being unable to properly regulate the heart’s rhythm and rate in some patients. Devices that Enter Safety Mode must be replaced.

The FDA is working with the manufacturer to assess the risk of this issue in all acclade pacimaker devices and to pinpoint additional mitigation strategies as needed.

Serious Adverse Health Consequences, Including Slow Heartbeats, Fainting, and Death, May Be Cauded by the Recalled devices. So far, 832 injuries and two deaths have been reported.

Physicians and patients should work togetra to monitor acclade pacmaker devices. For Patients at High Risk for Harm Associated with Interrupted Pacing that May Occur with Safety Mode, The device should be immediatively replaced. For other patients, a non-incident replacement is recommended. Any Problems EncounTed with Acclade Pacemaker Devices Should be Reported to the fda,

More information:
More information

2025 healthday. All rights reserved.

Citation: Manufacturer Recalls Accolade Pacemaker Devices (2025, February 25) RetrieVed 26 February 2025 From

This document is Subject to copyright. Apart from any Fair Dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

(Tagstotranslate) Medicine Research News (T) Medicine Research (T) Health Research News (T) Health Research (T) Health Science (T) Medicine Science

Leave a Comment

Your email address will not be published. Required fields are marked *